News
Antisense Therapeutics (ASX: ANP) has changed its name to Percheron Therapeutics - PER (ASX: PER).
Below are the previous articles from Antisense Therapeutics (ASX: ANP):
RELATED STOCKHEAD STORIES
News
Last Orders: Small caps dip again, but infant formula makers rise
News
Last Orders: Small caps rebound to finish day flat
Experts
ScoPo’s powerplays: Antisense ‘looks like it wants to run harder’
Health & Biotech
Check Up: Eco-fibre play Nanollose leads ASX healthcare sector with 292% gain
Experts
ScoPo’s powerplays: Searching for gems as healthcare sector languishes
News
Closing Bell: Today’s biggest small cap movers on the ASX
Experts
ScoPo’s Powerplays: Despite recent losses, healthcare is a great sector to be in
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Antisense Therapeutics receives FDA orphan designation for muscular dystrophy treatment
Experts
ScoPo’s Powerplays: Healthcare companies raised $1bn year-to-date
Experts
ScoPo’s Health Powerplays: Biotechs hitting it out of the park
Health & Biotech
Antisense’s DMD drug could have ‘profound’ impact on boys
News
Closing Bell: Today’s biggest small cap movers on the ASX
News
ASX Small Cap Lunch Wrap: Who’s trading insults today?
Health & Biotech
Antisense Therapeutics’ FDA ruling could be worth ‘hundreds of millions’
News
Rise and Shine: What you need to know before the ASX opens
News
